Telavancin in Hospital-Acquired and Ventilator-Associated Pneumonia (HAP/VAP) Caused by Staphylococcus aureus: Post Hoc Analysis of 2 Randomized, Controlled Trials

Telavancin in Hospital-Acquired and Ventilator-Associated Pneumonia (HAP/VAP) Caused by Staphylococcus aureus: Post Hoc Analysis of 2 Randomized, Controlled Trials

Abstract Introduction The efficacy and safety of telavancin versus vancomycin in microbiologically evaluable patients with hospital-acquired or ventilator-associated pneumonia (HAP/VAP) caused by Staphylococcus aureus with vancomycin minimum inhibitory concentration (MIC) ≥ 1.0 µg/mL was analyzed us...

Full description

Bibliographic Details
Main Authors: Michael S. Niederman, Patrick C. Lee, Steven L. Barriere, Chris N. Barnes, Bibiana Castaneda-Ruiz
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-08-01
Series:Infectious Diseases and Therapy
Subjects:
Hospital-acquired pneumonia
MRSA
Staphylococcus aureus
Telavancin
Vancomycin
Ventilator-associated pneumonia
Online Access:http://link.springer.com/article/10.1007/s40121-019-0255-0

Internet

http://link.springer.com/article/10.1007/s40121-019-0255-0

Similar Items